EKCS yields 500000.00% · JNJ yields 2.13%● Live data
📍 EKCS pulled ahead of the other in Year 1
Combined, EKCS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EKCS + JNJ for your $10,000?
Electronic Control Security Inc. designs, develops, manufactures, and markets technology-based integrated security solutions in the United States and the Middle East. The company offers entry control system, which regulates the passage of authorized vehicles and personnel into restricted areas; fiber optic intelligence and detection system; infrared perimeter intrusion detection systems provides dependable security barriers of pulsed infrared beams to create multiple detection zones; flight line security for aircraft parking areas, igloos and flight lines at air bases; rapid deployable intrusion detection systems; day/night and thermal imaging cameras; intelligent video motion detection; ARTSYS 360 - advanced radar technologies radar systems designed for detection and tracking of vehicles, humans, and drones; water infrastructure sensing equipment; and interoperable device management systems. It also provides site survey and risk assessment; design and engineering; systems manufacturing and integration; factory acceptance testing; installation supervision; and project commissioning services. The company was founded in 1976 and is headquartered in Clifton, New Jersey.
Full EKCS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.